Deciphera Pharmaceuticals, Inc. Stock-Based Compensation
Deciphera Pharmaceuticals, Inc. reported Stock-Based Compensation of $10.17 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-03-31 was $10.17M, a 18.70% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-12-31 was $14.07M, a 14.29% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-09-30 was $11.16M, a 9.80% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for the quarter ending 2023-06-30 was $12.86M, a 1.02% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $50.60M, a 2.58% decline from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $51.94M, a 12.73% increase from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $46.08M, a 24.08% increase from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $37.14M, a 81.95% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $10.17M 10-Q · filed 2024-05-10 | $24.25M derived: sum of 2 quarters · filed 2024-05-10 | $35.41M derived: sum of 3 quarters · filed 2024-05-10 | $48.26M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $14.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $25.23M derived: sum of 2 quarters · filed 2024-02-07 | $38.09M derived: sum of 3 quarters · filed 2024-02-07 | $50.60M 10-K · filed 2024-02-07 |
| 2023-09-30 | $11.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $24.02M derived: sum of 2 quarters · filed 2023-10-30 | $36.53M 10-Q · filed 2023-10-30 | $48.84M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $12.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $25.37M 10-Q · filed 2023-08-09 | $37.68M derived: sum of 3 quarters · filed 2024-05-10 | $50.06M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | $12.51M 10-Q · filed 2024-05-10 | $24.83M derived: sum of 2 quarters · filed 2024-05-10 | $37.20M derived: sum of 3 quarters · filed 2024-05-10 | $50.19M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $12.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $24.69M derived: sum of 2 quarters · filed 2024-02-07 | $37.67M derived: sum of 3 quarters · filed 2024-02-07 | $51.94M 10-K · filed 2024-02-07 |
| 2022-09-30 | $12.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $25.36M derived: sum of 2 quarters · filed 2023-10-30 | $39.63M 10-Q · filed 2023-10-30 | $50.42M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | $12.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $27.26M 10-Q · filed 2023-08-09 | $38.05M derived: sum of 3 quarters · filed 2024-02-07 | $49.84M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $14.27M 10-Q · filed 2023-05-03 | $25.06M derived: sum of 2 quarters · filed 2024-02-07 | $36.86M derived: sum of 3 quarters · filed 2024-02-07 | $49.23M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $10.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $22.59M derived: sum of 2 quarters · filed 2024-02-07 | $34.96M derived: sum of 3 quarters · filed 2024-02-07 | $46.08M 10-K · filed 2024-02-07 |
| 2021-09-30 | $11.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $24.16M derived: sum of 2 quarters · filed 2022-11-03 | $35.28M 10-Q · filed 2022-11-03 | $44.99M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $12.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $23.49M 10-Q · filed 2022-08-04 | $33.20M derived: sum of 3 quarters · filed 2023-02-07 | $43.02M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $11.12M 10-Q · filed 2022-05-04 | $20.82M derived: sum of 2 quarters · filed 2023-02-07 | $30.65M derived: sum of 3 quarters · filed 2023-02-07 | $41.26M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $19.53M derived: sum of 2 quarters · filed 2023-02-07 | $30.14M derived: sum of 3 quarters · filed 2023-02-07 | $37.14M 10-K · filed 2023-02-07 |
| 2020-09-30 | $9.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $20.44M derived: sum of 2 quarters · filed 2021-11-02 | $27.43M 10-Q · filed 2021-11-02 | $32.78M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $10.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $17.60M 10-Q · filed 2021-08-03 | $22.95M derived: sum of 3 quarters · filed 2022-02-08 | $27.68M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $6.99M 10-Q · filed 2021-05-04 | $12.34M derived: sum of 2 quarters · filed 2022-02-08 | $17.07M derived: sum of 3 quarters · filed 2022-02-08 | $21.18M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $5.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $10.07M derived: sum of 2 quarters · filed 2022-02-08 | $14.18M derived: sum of 3 quarters · filed 2022-02-08 | $20.41M 10-K · filed 2022-02-08 |
| 2019-09-30 | $4.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.84M derived: sum of 2 quarters · filed 2020-11-05 | $15.06M 10-Q · filed 2020-11-05 | $17.87M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $10.34M 10-Q · filed 2020-08-04 | $13.14M derived: sum of 3 quarters · filed 2021-02-09 | $15.76M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $6.23M 10-Q · filed 2020-05-05 | $9.03M derived: sum of 2 quarters · filed 2021-02-09 | $11.65M derived: sum of 3 quarters · filed 2021-02-09 | $13.88M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $5.42M derived: sum of 2 quarters · filed 2021-02-09 | $7.65M derived: sum of 3 quarters · filed 2021-02-09 | $9.69M 10-K · filed 2021-02-09 |
| 2018-09-30 | $2.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $4.85M derived: sum of 2 quarters · filed 2019-11-04 | $6.88M 10-Q · filed 2019-11-04 | $9.73M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | $2.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $4.27M 10-Q · filed 2019-08-02 | $7.11M derived: sum of 3 quarters · filed 2020-03-09 | $8.13M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | $2.04M 10-Q · filed 2019-05-09 | $4.88M derived: sum of 2 quarters · filed 2020-03-09 | $5.89M derived: sum of 3 quarters · filed 2020-03-09 | $6.49M derived: sum of 4 quarters · filed 2020-03-09 |
| 2017-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $3.86M derived: sum of 2 quarters · filed 2020-03-09 | $4.45M derived: sum of 3 quarters · filed 2020-03-09 | $4.87M 10-K · filed 2020-03-09 |
| 2017-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $1.61M derived: sum of 2 quarters · filed 2018-11-08 | $2.02M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $594.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $1.01M 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | $416.00K 10-Q · filed 2018-05-08 | |||
| 2016-12-31 | $1.49M 10-K · filed 2019-03-14 | |||
| 2015-12-31 | $2.56M 10-K · filed 2018-03-28 |